发明名称 Quinoxaline derivative
摘要 <p>The invention discloses quinoxaline derivatives or salts thereof having PDE9-inhibiting activity and being useful as treating agent of dysuria and the like, which are represented by the formula (I) in the formula, R 1 stands for C 1-6 alkyl, R 2 is absent, R 3 stands for alkyl, aryl, saturated carbocyclic group, saturated heterocyclic group, acyl and the like, R 4 stands for hydrogen, hydroxy, alkyl or amino, R 5 and R 8 each independently stands for hydrogen, halogen, alkyl, alkenyl, alkoxy, cyano or nitro, R 6 and R 7 each independently stands for hydrogen, halogen, alkyl, alkenyl, alkynyl, alkoxy, cyano, amino, carbocyclic group, heterocyclic group, COR 9 or SO 2 R 9 , R 9 stands for hydrogen, hydroxy, alkyl, amino, pyrrolidin-1-yl, piperidin-1-yl, pyperazin-1-yl or the like, X stands for S or O, and A 1 , A 2 and A 3 each independently stands for N or C.</p>
申请公布号 EP2489667(A1) 申请公布日期 2012.08.22
申请号 EP20120167114 申请日期 2007.12.12
申请人 ASKA PHARMACEUTICAL CO., LTD. 发明人 OKADA, MAKOTO;SATO, SHUICHIRO;KAWADE, KENJI;GOTANDA, KOTARO;SHINBO, ATSUSHI;NAKANO, YOUICHI;KOBAYASHI, HIDEO
分类号 C07D487/04;A61K31/4985;A61P3/10;A61P7/02;A61P9/10;A61P9/12;A61P11/16;A61P13/02;A61P13/08;A61P13/10;A61P15/10;A61P25/00;A61P25/28 主分类号 C07D487/04
代理机构 代理人
主权项
地址